• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

发现非肽小分子 CXCR4 拮抗剂作为抗 HIV 药物:最新进展和未来机遇。

Discovery of non-peptide small molecular CXCR4 antagonists as anti-HIV agents: Recent advances and future opportunities.

机构信息

Department of Medicinal Chemistry, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Shandong University, 44, West Culture Road, 250012 Jinan, Shandong, PR China.

Department of Medicinal Chemistry, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Shandong University, 44, West Culture Road, 250012 Jinan, Shandong, PR China.

出版信息

Eur J Med Chem. 2016 May 23;114:65-78. doi: 10.1016/j.ejmech.2016.02.051. Epub 2016 Feb 24.

DOI:10.1016/j.ejmech.2016.02.051
PMID:26974376
Abstract

CXCR4 plays vital roles in HIV-1 life cycle for it's essential in mediating the interaction of host and virus and completing the entry process in the lifecycle of HIV-1 infection. Compared with some traditional targets, CXCR4 provides a novel and less mutated drug target in the battle against AIDS. Its antagonists have no cross resistance with other antagonists. Great achievements have been made recent years and a number of small molecular CXCR4 antagonists with diversity scaffolds have been discovered. In this review, recent advances in the discovery of CXCR4 antagonists with special attentions on their evolution and structure-activity relationships of representative CXCR4 antagonists are described. Moreover, some classical medicinal chemistry strategies and novel methodologies are also introduced.

摘要

CXCR4 在 HIV-1 生命周期中发挥着至关重要的作用,因为它在介导宿主和病毒的相互作用以及完成 HIV-1 感染生命周期中的进入过程中是必不可少的。与一些传统靶点相比,CXCR4 为抗艾滋病斗争提供了一个新颖且突变较少的药物靶点。其拮抗剂与其他拮抗剂没有交叉耐药性。近年来取得了重大进展,发现了许多具有多样性骨架的小分子 CXCR4 拮抗剂。本文综述了 CXCR4 拮抗剂的发现进展,特别关注了代表性 CXCR4 拮抗剂的进化和构效关系,此外还介绍了一些经典的药物化学策略和新方法。

相似文献

1
Discovery of non-peptide small molecular CXCR4 antagonists as anti-HIV agents: Recent advances and future opportunities.发现非肽小分子 CXCR4 拮抗剂作为抗 HIV 药物:最新进展和未来机遇。
Eur J Med Chem. 2016 May 23;114:65-78. doi: 10.1016/j.ejmech.2016.02.051. Epub 2016 Feb 24.
2
Anti-HIV small-molecule binding in the peptide subpocket of the CXCR4:CVX15 crystal structure.抗HIV小分子在CXCR4:CVX15晶体结构的肽亚口袋中的结合情况。
Chembiochem. 2014 Jul 21;15(11):1614-20. doi: 10.1002/cbic.201402056. Epub 2014 Jul 2.
3
Peptide-lead CXCR4 antagonists with high anti-HIV activity.具有高抗HIV活性的肽类先导CXCR4拮抗剂。
Curr Opin Investig Drugs. 2001 Sep;2(9):1198-202.
4
Impact of the CXCR4 structure on docking-based virtual screening of HIV entry inhibitors.CXCR4 结构对基于对接的 HIV 进入抑制剂虚拟筛选的影响。
J Mol Graph Model. 2012 Sep;38:123-36. doi: 10.1016/j.jmgm.2012.06.010. Epub 2012 Jul 3.
5
The chemical diversity and structure-based evolution of non-peptide CXCR4 antagonists with diverse therapeutic potential.具有多种治疗潜力的非肽类CXCR4拮抗剂的化学多样性及基于结构的进化
Eur J Med Chem. 2018 Apr 10;149:148-169. doi: 10.1016/j.ejmech.2018.02.043. Epub 2018 Feb 17.
6
Structure-based development of antagonists for chemokine receptor CXCR4.基于结构的趋化因子受体CXCR4拮抗剂的开发
Curr Comput Aided Drug Des. 2013 Mar;9(1):60-75.
7
Pharmacophore-based small molecule CXCR4 ligands.基于药效基团的小分子 CXCR4 配体。
Bioorg Med Chem Lett. 2012 Jun 15;22(12):4169-72. doi: 10.1016/j.bmcl.2012.04.032. Epub 2012 Apr 20.
8
Synthesis and Anti-HIV Activity of a Novel Series of Isoquinoline-Based CXCR4 Antagonists.新型异喹啉基CXCR4拮抗剂系列的合成及其抗HIV活性
Molecules. 2021 Oct 18;26(20):6297. doi: 10.3390/molecules26206297.
9
Progress toward rationally designed small-molecule peptide and peptidomimetic CXCR4 antagonists.合理设计的小分子肽和肽模拟物CXCR4拮抗剂的研究进展。
Future Med Chem. 2015;7(10):1261-83. doi: 10.4155/fmc.15.64.
10
Azamacrocyclic metal complexes as CXCR4 antagonists.作为 CXCR4 拮抗剂的大环金属配合物。
ChemMedChem. 2011 May 2;6(5):834-9. doi: 10.1002/cmdc.201000548. Epub 2011 Feb 10.

引用本文的文献

1
Molecular Docking Studies of Targeting HIV Co-Receptor CXCR4.靶向HIV共受体CXCR4的分子对接研究
Curr HIV Res. 2025;23(2):107-120. doi: 10.2174/011570162X345178250316123743.
2
HIV-1 Reverse Transcriptase/Integrase Dual Inhibitors: A Review of Recent Advances and Structure-activity Relationship Studies.HIV-1逆转录酶/整合酶双重抑制剂:近期进展及构效关系研究综述
Iran J Pharm Res. 2021 Spring;20(2):333-369. doi: 10.22037/ijpr.2021.115446.15370.
3
Profile of Circulatory Cytokines and Chemokines in Human Coronaviruses: A Systematic Review and Meta-Analysis.
循环细胞因子和趋化因子在人类冠状病毒中的特征:系统评价和荟萃分析。
Front Immunol. 2021 May 5;12:666223. doi: 10.3389/fimmu.2021.666223. eCollection 2021.
4
Chemokines and chemokine receptors during COVID-19 infection.新型冠状病毒肺炎感染期间的趋化因子与趋化因子受体
Comput Struct Biotechnol J. 2021;19:976-988. doi: 10.1016/j.csbj.2021.01.034. Epub 2021 Jan 27.
5
Discoveries and developments of CXCR4-targeted HIV-1 entry inhibitors.CXCR4 靶向 HIV-1 进入抑制剂的发现和发展。
Exp Biol Med (Maywood). 2020 Mar;245(5):477-485. doi: 10.1177/1535370220901498. Epub 2020 Feb 4.
6
Synthetic Activators of Cell Migration Designed by Constructive Machine Learning.通过建设性机器学习设计的细胞迁移合成激活剂
ChemistryOpen. 2019 Oct 23;8(10):1303-1308. doi: 10.1002/open.201900222. eCollection 2019 Oct.
7
A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators.一种基于动力学荧光的Ca2+动员检测方法,用于鉴定G蛋白偶联受体激动剂、拮抗剂和变构调节剂。
J Vis Exp. 2018 Feb 20(132):56780. doi: 10.3791/56780.
8
Anti-inflammatory hybrids of secondary amines and amide-sulfamide derivatives.仲胺与酰胺 - 磺酰胺衍生物的抗炎杂合物。
Eur J Med Chem. 2018 Apr 25;150:195-205. doi: 10.1016/j.ejmech.2018.02.085. Epub 2018 Mar 2.
9
Chemokines and Chemokine Receptors: Accomplices for Human Immunodeficiency Virus Infection and Latency.趋化因子与趋化因子受体:人类免疫缺陷病毒感染及潜伏的帮凶
Front Immunol. 2017 Oct 16;8:1274. doi: 10.3389/fimmu.2017.01274. eCollection 2017.
10
Novel anti-inflammatory agents targeting CXCR4: Design, synthesis, biological evaluation and preliminary pharmacokinetic study.靶向CXCR4的新型抗炎剂:设计、合成、生物学评价及初步药代动力学研究
Eur J Med Chem. 2017 Aug 18;136:360-371. doi: 10.1016/j.ejmech.2017.05.030. Epub 2017 May 10.